Skip to main content
INM filings

Corporate insider profile

Daniel Schneeberger Filing Activity

Latest reported as Corporate insider of InMed Pharmaceuticals Inc. (INM).

Purchase filings
5
Reported companies
2
Net open-market value
$4,950,822
Latest transaction
May 19, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 19, 2026InMed Pharmaceuticals Inc. (INM)Corporate insiderOpen Market Purchase468,551$1.54$721,569
May 19, 2026Rallybio Corp (RLYB)Corporate insiderOpen Market Purchase16,209$13.98$226,563
May 15, 2026Rallybio Corp (RLYB)Corporate insiderOpen Market Purchase79,559$13.99$1,112,975